Stocks and Investing
Stocks and Investing
Thu, August 15, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joseph Pantginis Reiterated (atyr) at Strong Buy and Held Target at $35 on, Aug 15th, 2024
Joseph Pantginis of HC Wainwright & Co., Reiterated "aTyr Pharma, Inc." (ATYR) at Strong Buy and Held Target at $35 on, Aug 15th, 2024.
Joseph has made no other calls on ATYR in the last 4 months.
There is 1 other peer that has a rating on ATYR. Out of the 1 peers that are also analyzing ATYR, 0 agree with Joseph's Rating of Hold.
This is the rating of the analyst that currently disagrees with Joseph
- Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $16 on, Wednesday, August 14th, 2024
Contributing Sources